Relmada Therapeutics, Inc. (RLMD)

Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $23.19 million. The enterprise value is -$3.92 million.

Market Cap	23.19M
Enterprise Value	-3.92M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

RLMD has 33.19 million shares outstanding. The number of shares has increased by 0.42% in one year.

Current Share Class	33.19M
Shares Outstanding	33.19M
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	+0.78%
Owned by Insiders (%)	10.85%
Owned by Institutions (%)	18.93%
Float	24.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.03
P/TBV Ratio	1.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.29

Current Ratio	5.29
Quick Ratio	5.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -160.26% and return on invested capital (ROIC) is -104.67%.

Return on Equity (ROE)	-160.26%
Return on Assets (ROA)	-88.24%
Return on Invested Capital (ROIC)	-104.67%
Return on Capital Employed (ROCE)	-352.47%
Revenue Per Employee	n/a
Profits Per Employee	-$4.45M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.71% in the last 52 weeks. The beta is 0.66, so RLMD's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-76.71%
50-Day Moving Average	0.42
200-Day Moving Average	1.45
Relative Strength Index (RSI)	64.79
Average Volume (20 Days)	825,928

Short Selling Information

The latest short interest is 1.22 million, so 3.67% of the outstanding shares have been sold short.

Short Interest	1.22M
Short Previous Month	2.03M
Short % of Shares Out	3.67%
Short % of Float	4.97%
Short Ratio (days to cover)	0.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-79.12M
Pretax Income	-86.76M
Net Income	-75.71M
EBITDA	n/a
EBIT	-79.12M
Earnings Per Share (EPS)	-$2.50

Balance Sheet

The company has $27.06 million in cash and n/a in debt, giving a net cash position of $27.06 million or $0.82 per share.

Cash & Cash Equivalents	27.06M
Total Debt	n/a
Net Cash	27.06M
Net Cash Per Share	$0.82
Equity (Book Value)	22.44M
Book Value Per Share	0.68
Working Capital	22.43M

Cash Flow

Operating Cash Flow	-56.79M
Capital Expenditures	n/a
Free Cash Flow	-56.79M
FCF Per Share	-$1.71

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.42%
Shareholder Yield	-0.42%
Earnings Yield	-327.12%
FCF Yield	-245.35%

Analyst Forecast

The average price target for RLMD is $4.25, which is 508.36% higher than the current price. The consensus rating is "Hold".

Price Target	$4.25
Price Target Difference	508.36%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-25.92%

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Sep 30, 2019
Split Type	Reverse
Split Ratio	0.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1